LifeMD, Inc. (LFMD)

LifeMD Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-23.36	-23.7	-48.64	-61.77	-63.36	-3.14
Depreciation & Amortization	7.33	6.6	3.77	0.87	0.4	0.34
Share-Based Compensation	12.37	12.49	13.73	12.07	36.96	0.75
Other Operating Activities	20.29	10.33	5.1	14.87	9.16	2.3
Operating Cash Flow	16.64	8.82	-22.94	-33.09	-12.13	0.25
Capital Expenditures	-8.96	-8.58	-8.89	-3.38	-0.4	0
Acquisitions	0	0	-1.01	0	-0.4	-0.1
Other Investing Activities	-0.15	-0.15	-4	-0.02	-	-
Investing Cash Flow	-9.11	-8.73	-13.91	-3.4	-0.8	-0.1
Share Issuance / Repurchase	16.3	16.3	0.13	15.14	18.16	0.35
Debt Issued / Paid	3.29	16.67	2.74	-0.53	0.08	0.51
Other Financing Activities	-3.53	-3.87	-3.39	54.03	2.76	-0.09
Financing Cash Flow	16.06	29.1	-0.53	68.64	21	0.78
Net Cash Flow	23.59	29.19	-37.37	32.15	8.07	0.93
Free Cash Flow	7.67	0.24	-31.83	-36.47	-12.53	0.25
Free Cash Flow Margin	4.69%	0.15%	-26.74%	-39.26%	-33.60%	2.02%
Free Cash Flow Per Share	0.20	0.01	-1.03	-1.35	-0.88	0.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).